{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:46:01Z","timestamp":1770990361252,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":6428,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1254\/jjp.88.379","type":"journal-article","created":{"date-parts":[[2002,8,26]],"date-time":"2002-08-26T16:44:18Z","timestamp":1030380258000},"page":"379-397","source":"Crossref","is-referenced-by-count":80,"title":["Pharmacological, Pharmacokinetic and Clinical Properties of Olopatadine Hydrochloride, a New Antiallergic Drug"],"prefix":"10.1016","volume":"88","author":[{"given":"Kenji","family":"Ohmori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Kaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuo","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimichi","family":"Mukouyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.88.379_bib1","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1021\/jm00089a020","article-title":"Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives","volume":"35","author":"Ohshima","year":"1992","journal-title":"J Med Chem"},{"key":"10.1254\/jjp.88.379_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1254\/fpj.106.289","article-title":"Pharmacological studies on KW-4679, an antiallergic drug (1): inhibitory effect on passive cutaneous anaphylaxis (PCA) and experimental asthma in rats and guinea pigs","volume":"106","author":"Ishii","year":"1995","journal-title":"Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi)"},{"key":"10.1254\/jjp.88.379_bib3","first-page":"3543","article-title":"Pharmacological studies on KW-4679, an antiallergic drug -inhibitory effect on passive cutaneous anaphylaxis (PCA) and bronchoconstriction in rats and guinea pigs","volume":"29","author":"Ishii","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib4","first-page":"1229","article-title":"The effect of KW-4679, an antiallergic drug, on experimental allergic rhinitis","volume":"44","author":"Kaise","year":"1995","journal-title":"Jpn J Allergol"},{"key":"10.1254\/jjp.88.379_bib5","first-page":"1005","article-title":"Effect of (Z)-11-[3-(dimethylamino)propyllidene]-6,11-dihydrobenz[b,e] oxepin-2-acetic acid hydrochloride on experimental allergic conjunctivitis and rhinitis in rats and guinea pigs","volume":"45","author":"Kamei","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.88.379_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1398-9995.1997.tb04878.x","article-title":"Mediators of nasal blockage in allergic rhinitis","volume":"52","author":"Howarth","year":"1997","journal-title":"Allergy"},{"key":"10.1254\/jjp.88.379_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2500\/105065899782106724","article-title":"Accuracy of measurement of acoustic rhinometry applied to small experimental animals","volume":"13","author":"Kaise","year":"1999","journal-title":"Am J Rhinology"},{"key":"10.1254\/jjp.88.379_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1254\/jjp.69.435","article-title":"The effect of KW-4679, an antiallergic drug, on experimental allergic rhinitis in guinea pigs: effects on nasal blockage","volume":"69","author":"Kaise","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0091-6749(94)90140-6","article-title":"Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy","volume":"94","author":"Terada","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1254\/jjp.88.379_bib10","first-page":"187","article-title":"Inhibitory effect of KW-4679 on the infiltration of eosinophils in the nasal mucosa of rat allergic rhinitis models","volume":"29","author":"Akagi","year":"2001","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1254\/jjp.88.379_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000236837","article-title":"Effects of oxatomide and KW-4679 on acetylcholine-induced responses in the isolated acini of guinea pig glands","volume":"106","author":"Ikeda","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1254\/jjp.88.379_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000237312","article-title":"Effects of KW-4679, a new orally active antiallergic drug, on antigen-induced bronchial hyperresponsiveness, airway inflammation and immediate and late asthmatic responses in guinea pigs","volume":"72","author":"Ohmori","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1254\/jjp.88.379_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1254\/jjp.70.277","article-title":"Effect of KW-4679, an orally active antiallergic drug, on antigen-induced airway hyperresponsiveness in actively sensitized guinea pigs","volume":"70","author":"Kawasaki","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/jappl.1960.15.3.325","article-title":"Control of respiratory frequency","volume":"15","author":"Mead","year":"1960","journal-title":"J Appl Physiol"},{"key":"10.1254\/jjp.88.379_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1254\/fpj.118.15","article-title":"Histamine produced by macrophage and T lymphocyte: a new type of signal transducer","volume":"118","author":"Nakano","year":"2001","journal-title":"Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi)"},{"key":"10.1254\/jjp.88.379_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2567.2000.00986.x","article-title":"Analysis of histamine-producing cells at the late phase of allergiic inflammation in rats","volume":"99","author":"Shiraishi","year":"2000","journal-title":"Immunology"},{"key":"10.1254\/jjp.88.379_bib17","doi-asserted-by":"crossref","first-page":"87P","DOI":"10.1016\/S0021-5198(19)51260-4","article-title":"Effect of KW-4679, a novel antiallergic agent, on histamine Hi receptor","volume":"I","author":"Nonaka","year":"1993","journal-title":"Jpn J Pharmacol 61, Suppl"},{"key":"10.1254\/jjp.88.379_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jop.1996.12.401","article-title":"Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting Hi-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis","volume":"12","author":"Sharif","year":"1996","journal-title":"J Ocular Pharmacol"},{"key":"10.1254\/jjp.88.379_bib19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1006\/bbrc.1994.2295","article-title":"Site-directed mutagenesis of the histamine Hi receptor: role of asparatic acid107, asparaginase198 and threonine194","volume":"203","author":"Ohta","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.88.379_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(97)01620-8","article-title":"Unique binding pocket for KW-4679 in the histamine H1 receptor","volume":"345","author":"Nonaka","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib21","first-page":"1817","article-title":"The antihistaminic effect of KW-4679, a novel antiallergic drug","volume":"5","author":"Sasaki","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1254\/jjp.88.379_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4049\/jimmunol.155.2.525","article-title":"Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling","volume":"155","author":"Ley","year":"1995","journal-title":"J Immunol"},{"key":"10.1254\/jjp.88.379_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/cimm.1996.0205","article-title":"Histamine enhanced the TNF-a-induced expression of E-selectin and ICAM-1 on vascular endothelial cells","volume":"171","author":"Miki","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1254\/jjp.88.379_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000237162","article-title":"Histamine activates bronchial epithelial cells to release inflammatory cytokines in vitro","volume":"108","author":"Takizawa","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1254\/jjp.88.379_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archopht.117.5.643","article-title":"Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs","volume":"117","author":"Yanni","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1254\/jjp.88.379_bib26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1476-5381.1990.tb14177.x","article-title":"Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airway","volume":"101","author":"Sirois","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hyper-sensitivity reaction and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"key":"10.1254\/jjp.88.379_bib28","first-page":"1837","article-title":"Effect of KW-4679, an novel antiallergic drug, on histamine and leukotriene release from rat peritoneal exudates cells","volume":"5","author":"Sasaki","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1254\/jjp.88.379_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1081-1206(10)63063-3","article-title":"Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells","volume":"79","author":"Yanni","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1254\/jjp.88.379_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000237311","article-title":"KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophiles","volume":"110","author":"Ikemura","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1254\/jjp.88.379_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1440-1592.2001.00207.x","article-title":"Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophiles","volume":"50","author":"Miyake","year":"2001","journal-title":"Allergol Int"},{"key":"10.1254\/jjp.88.379_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1254\/jjp.85.453","article-title":"Effect of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs","volume":"85","author":"Miyake","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1440-1592.2001.00236.x","article-title":"Effects of olopatadine hydrochloride on the release of thromboxane B2 and histamine from nasal mucosa after antigen-antibody reaction in guinea pigs","volume":"50","author":"Kaise","year":"2001","journal-title":"Allergol Int"},{"key":"10.1254\/jjp.88.379_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/000348949910800509","article-title":"Comparative role of peptide leukotrienes and hista-mine in the development of nasal mucosal swelling in nasal allergy","volume":"108","author":"Numata","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1254\/jjp.88.379_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/00016489850182323","article-title":"The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis","volume":"537","author":"Terada","year":"1998","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1254\/jjp.88.379_bib36","doi-asserted-by":"crossref","first-page":"s16","DOI":"10.1164\/ajrccm\/136.6_Pt_2.S16","article-title":"Coexistence of multiple peptide and classical transmitters in airway neurons: functional and pathophysiologic aspects","volume":"136","author":"Lundberg","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1254\/jjp.88.379_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0091-6749(89)90441-7","article-title":"New concepts in the pathogenesis of bronchial hyper-responsiveness and asthma","volume":"83","author":"Barnes","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1254\/jjp.88.379_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/arrd.1985.131.4.599","article-title":"Damage of the airway epithelium and bronchial reactivity in patients with asthma","volume":"131","author":"Laitinen","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1254\/jjp.88.379_bib39","first-page":"L507","article-title":"Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea pig","volume":"265","author":"Bertrand","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1254\/jjp.88.379_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1981.tb00884.x","article-title":"Pharmacological characterization of the guinea pig tracheo-bronchial smooth muscle","volume":"49","author":"Grundstr\u00f6m","year":"1981","journal-title":"Acta Pharmacol Toxicol"},{"key":"10.1254\/jjp.88.379_bib41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1476-5381.1996.tb15289.x","article-title":"KW-4679-induced inhibition of tachykininergic contraction in the guinea-pig bronchi by prejunctional inhibition of peripheral sensory nerve","volume":"117","author":"Ikemura","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib42","doi-asserted-by":"crossref","first-page":"PL101","DOI":"10.1016\/0024-3205(92)90352-P","article-title":"A potent and selective non-peptide antagonist of neurokinin A (NK2) receptor","volume":"50","author":"Emonds-Alt","year":"1992","journal-title":"Life Sci"},{"key":"10.1254\/jjp.88.379_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1254\/jjp.71.179","article-title":"Inhibitory effect of KW-4679, an anti-allergic drug, on tachykinin-mediated airway response induced by electrical vagal stimulation in guinea pigs","volume":"71","author":"Ikemura","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1165\/ajrcmb\/4.3.228","article-title":"Substance P and neurokinin A in human nasal mucosa","volume":"4","author":"Baraniuk","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1254\/jjp.88.379_bib45","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/000348949910801008","article-title":"Expression of NPY Y1 and CGRP receptors in human nasal mucosa: implications in allergic rhinitis","volume":"108","author":"Uddman","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1254\/jjp.88.379_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1164\/ajrccm\/144.3_Pt_1.630","article-title":"Clinical and inflammatory responses to exogeneous tachykinins in allergic rhinitis","volume":"144","author":"Braunstein","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1254\/jjp.88.379_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/BF00917475","article-title":"Mediation of prolonged increases in nasal mucosal blood flow by calcitonin gene-related peptide (CGRP)","volume":"10","author":"Ranji","year":"1990","journal-title":"J Clin Immunol"},{"key":"10.1254\/jjp.88.379_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/000348949610500811","article-title":"Role of substance P in the vascular response of nasal mucosa in nasal allergy","volume":"105","author":"Konno","year":"1996","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1254\/jjp.88.379_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1254\/jjp.86.196","article-title":"Involvement of neuropeptides in the allergic nasal obstruction in guinea pigs","volume":"86","author":"Kaise","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib50","first-page":"737","article-title":"Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist","volume":"275","author":"Gitter","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.88.379_bib51","first-page":"1084","article-title":"Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide receptors in brain and periphery","volume":"258","author":"Mimeault","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.88.379_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1254\/jjp.86.258","article-title":"Inhibitory effect of olopatadine hydrochloride on the sneezing response induced by intranasal capsaicin challenge in guinea pigs","volume":"86","author":"Kaise","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00505327","article-title":"Local and systemic capsaicin pretreatment inhibits sneezing and the increase in nasal permeability induced by certain chemical irritants","volume":"326","author":"Lundblad","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1254\/jjp.88.379_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02028116","article-title":"Substance P as a potent stimulator of sneeze responses in experimental allergic rhinitis of guinea pigs","volume":"37","author":"Imamura","year":"1992","journal-title":"Agents Actions"},{"key":"10.1254\/jjp.88.379_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/00016489309126188","article-title":"Effects of topical capsaicin on autonomic nerves in experimentally-induced nasal hypersensitivity. An immunocytochemical study","volume":"500","author":"Kitajiri","year":"1993","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1254\/jjp.88.379_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1476-5381.1988.tb10305.x","article-title":"Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man","volume":"93","author":"Geppetti","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib57","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1523\/JNEUROSCI.20-11-04345.2000","article-title":"\u03bc-Opioid receptors often colocalize with substance P receptor (NK1) in the trigemi-nal dorsal horn","volume":"20","author":"Aicher","year":"2000","journal-title":"J Neurosci"},{"key":"10.1254\/jjp.88.379_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12538380","article-title":"Localization of eosinophil granule major basic protein in chronic urticaria","volume":"81","author":"Peters","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1254\/jjp.88.379_bib59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2133.1995.tb06916.x","article-title":"Immunohistological comparison of granulated cell proteins in immediate urticarial dermographism and delayed pressure urticaria lesions","volume":"133","author":"Mcevoy","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1254\/jjp.88.379_bib60","first-page":"414","article-title":"Production of wheal-and-flare skin reactions by eosinophil granule proteins","volume":"82","author":"Leiferman","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1254\/jjp.88.379_bib61","doi-asserted-by":"crossref","first-page":"12559","DOI":"10.1016\/S0021-9258(18)37791-3","article-title":"Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein","volume":"263","author":"Wasmoen","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1254\/jjp.88.379_bib62","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/ajrccm\/147.4.896","article-title":"Cationic proteins induce airway hyperresponsiveness dependent on charge interactions","volume":"147","author":"Coyle","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1254\/jjp.88.379_bib63","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1164\/ajrccm\/147.4.982","article-title":"The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations","volume":"147","author":"Uchida","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1254\/jjp.88.379_bib64","first-page":"243","article-title":"The effect of polyamino acids on the blood vessels of the rat","volume":"57","author":"Stein","year":"1956","journal-title":"Arch Int Pharmacodyn"},{"key":"10.1254\/jjp.88.379_bib65","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1113\/jphysiol.1983.sp014543","article-title":"Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin","volume":"335","author":"Foreman","year":"1983","journal-title":"J Physiol (Lond)"},{"key":"10.1254\/jjp.88.379_bib66","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1476-5381.1989.tb12030.x","article-title":"Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli","volume":"97","author":"Benyon","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib67","first-page":"L1096","article-title":"Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons","volume":"273","author":"Garland","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1254\/jjp.88.379_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0014-2999(01)01177-3","article-title":"Roles of mast cells and sensory nerves in cutaneous vascular hyperpermeability and scratching behavior induced by poly-L-arginine in rats","volume":"425","author":"Hayashi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jjp.87.167","article-title":"Effects of olopatadine hydrochloride on the cutaneous vascular hyper-permeability and scratching behavior induced by poly-L-arginine in rat","volume":"87","author":"Hayashi","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib70","first-page":"1421","article-title":"General pharmacology of KW-4679, an antiallergic drug (1st report) - effects on central nervous system, autonomic nervous system and peripheral nervous system -","volume":"5","author":"Ishii","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1254\/jjp.88.379_bib71","first-page":"2155","article-title":"General pharmacology of KW-4679, an antiallergic drug (2 nd report) - effects on respiratory and circulatory system, urogenital system and digestive system","volume":"5","author":"Ishii","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1254\/jjp.88.379_bib72","first-page":"4727","article-title":"A single dose toxicity study of KW-4679 in mice, rats and dogs","volume":"29","author":"Saeki","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib73","first-page":"4749","article-title":"Toxicity studies of KW-4679 - a 13-week repeated dose toxicity study in rats","volume":"29","author":"Ikegami","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib74","first-page":"4787","article-title":"Toxicity studies of KW-4679 - a 52 week repeated dose toxicity study in dogs","volume":"29","author":"Ikegami","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib75","first-page":"4803","article-title":"Reproductive and developmental toxicity study of KW-4679 - fertility study in rats","volume":"29","author":"Naya","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib76","first-page":"4815","article-title":"Reproductive and developmental toxicity study of KW-4679 - teratogenicity study in rat","volume":"29","author":"Naya","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib77","first-page":"4841","volume":"29","author":"Naya","year":"1995","journal-title":"Reproductive and developmental study of KW-4679 - terato-genecity study in rabbits"},{"key":"10.1254\/jjp.88.379_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.83.1","article-title":"Drug-induced torsades de pointes: from molecular biology to bedside","volume":"83","author":"Tamargo","year":"2000","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1254\/jjp.70.199","article-title":"Effect of terfena-dine and KW-4679, a novel antiallergic compound, on action potential of guinea pig ventricular myocytes","volume":"70","author":"Kato","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.88.379_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-3623(95)02004-7","article-title":"Inhibitory effects of terfenadine on the rising phase of action potentials and sinus rates in isolated guinea-pig myocardium","volume":"27","author":"Tanaka","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1254\/jjp.88.379_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00315505","article-title":"Itraconazole prevents terfenadine metabolism and increase risk of torsades de pointes ventricular tachycardia","volume":"45","author":"Pohjola-Sintonen","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1254\/jjp.88.379_bib82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1254\/fpj.117.401","article-title":"Effect of olopatadine hydrochloride, a novel antiallergic agent, on the QT interval","volume":"711","author":"Iwamoto","year":"2001","journal-title":"Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi)"},{"key":"10.1254\/jjp.88.379_bib83","first-page":"4129","article-title":"Phase I clinical study on KW-4679, an antiallergic drug - safety and pharmacokinetics in the single and repeated administration. study to healthy subjects","volume":"29","author":"Tsunoo","year":"1995","journal-title":"Clin Report"},{"key":"10.1254\/jjp.88.379_bib84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0378-4347(99)00236-4","article-title":"Determination of olopata-dine, a new antiallergic agent, and its metabolites in human plasma by high-performance liquid chromatography with elec-trospray ionization tandem mass spectrometry","volume":"731","author":"Fujita","year":"1999","journal-title":"J Chromatogr"},{"key":"10.1254\/jjp.88.379_bib85","first-page":"1","article-title":"Pharmacokinetics of KW-4679 in the elderly: single-dose and multiple-dose trials","volume":"29","author":"Tateishi","year":"1998","journal-title":"Drugs Exp Clin Res"},{"key":"10.1254\/jjp.88.379_bib86","first-page":"107","article-title":"Pharmacokinetics of KW-4679 in patients with renal insufficiency","volume":"42","author":"Koshikawa","year":"1997","journal-title":"Kidney and Dialysis"},{"key":"10.1254\/jjp.88.379_bib87","first-page":"707","article-title":"Disposition of KW-4679 (6): pharmacokinetics in experimental animals","volume":"10","author":"Kuwabara","year":"1995","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib88","first-page":"651","article-title":"Disposition of KW-4679 (1): absorption, distribution and excretion of 14C-KW-4679 after oral or intravenous administration to rats","volume":"10","author":"Ohishi","year":"1995","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib89","first-page":"683","article-title":"Disposition of KW-4679 (3): absorption and excretion of 14C-KW-4679 after oral administration to dogs","volume":"10","author":"Ohishi","year":"1995","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib90","first-page":"483","article-title":"Pharmacokinetic studies on 14C-epinastine hydrochloride (WAL 801 Cl) (I). Blood level, tissue distribution and urinary and fecal excretion after single and repeated administration in rats","volume":"20","author":"Oiwa","year":"1992","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1254\/jjp.88.379_bib91","first-page":"133","article-title":"The biological fate of 1-(2-ethoxyethyl)-2-(4-methyl-1-homo-piperazinyl)benzimidazole difumarate (KB-2413). II. distribution after single and multiple oral administration to rats","volume":"2","author":"Sasaki","year":"1987","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib92","first-page":"1173","article-title":"Metabolic disposition of terfenadine in laboratory animals","volume":"32","author":"Leeson","year":"1982","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.88.379_bib93","first-page":"707","article-title":"Disposition of KW-4679 (5): transfer of 14C-KW-4679 to fetus and milk after oral administration to rats","volume":"10","author":"Ohishi","year":"1995","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib94","first-page":"689","article-title":"Disposition of KW-4679 (4): metabolism of KW-4679 in rats and dogs","volume":"10","author":"Ohishi","year":"1995","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib95","first-page":"669","article-title":"Disposition of KW-4679 (2): absorption, distribution, excretion of 14C-KW-4679 after multiple oral administrations in rats and effect of KW-4679 on drug metabolizing enzyme in rats","volume":"10","author":"Ohishi","year":"1995","journal-title":"Xenobio Metabol Dispos"},{"key":"10.1254\/jjp.88.379_bib96","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1365-2222.1994.tb02728.x","article-title":"Comparison of a new antihistaminic and antiallergic compound KW4679 with terfenadine and placebo on skin and nasal provocation in atopic individuals","volume":"24","author":"Hamilton","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"10.1254\/jjp.88.379_bib97","first-page":"191","article-title":"Early phase II study of KW-4679 (olopatadine hydro-chloride) on chronic urticaria","volume":"17","author":"Nishiyama","year":"2001","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib98","first-page":"211","article-title":"Late phase II study of KW-4679 (olopatadine hydrochloride) on chronic urticaria - optimal dose finding study by double blind technique","volume":"17","author":"Nishiyama","year":"2001","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib99","first-page":"237","article-title":"Phase III study of KW-4679 (olopatadine hydro-chloride) on chronic urticaria - a double blind study in comparison with ketotifen fumarate","volume":"17","author":"Nishiyama","year":"2001","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib100","first-page":"1597","article-title":"Long-term treatment of KW-4679 (olopatadine hydro-chloride) on chronic urticaria","volume":"12","author":"Nishiyama","year":"1996","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib101","first-page":"1615","article-title":"Clinical study of KW-4679 (olopatadine hydrochloride) on pruritic diseases","volume":"12","author":"Nishiyama","year":"1996","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib102","first-page":"1543","article-title":"Safety and efficacy of KW-4679 (olopatadine hydrochloride) tablets in bronchial asthma - early phase II study -","volume":"12","author":"Miyamoto","year":"1996","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib103","first-page":"87","article-title":"Late phase II study for optimal dose finding of KW-4679 (olopatadine hydrochloride) tablets in bronchial asthma - multi-center double-blind study compared with placebo control","volume":"17","author":"Miyamoto","year":"2001","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib104","first-page":"1883","article-title":"Usefulness of KW-4679 (olopatadine hydrochloride) tablets in bronchial asthma - multicenter double-blind study compared with terfenadine","volume":"12","author":"Miyamoto","year":"1996","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib105","first-page":"1935","article-title":"A long-term administration study of KW-4679 (olopatadine hydrochloride) tablets on bronchial asthma","volume":"12","author":"Sano","year":"1996","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib106","first-page":"1915","article-title":"Long-term use experience of KW-4679 (olopatadine hydro-chloride) tablets in bronchial asthma","volume":"12","author":"Yamakido","year":"1996","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.88.379_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00055735-199808000-00010","article-title":"The current and future therapy of allergic conjunctivitis","volume":"9","author":"Friedlaender","year":"1998","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1254\/jjp.88.379_bib108","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1081-1206(10)62814-1","article-title":"Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using conjunctival allergen challenge","volume":"81","author":"Abelson","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1254\/jjp.88.379_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0420.1999.tb01174.x","article-title":"Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model","volume":"77","author":"Deschenes","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1254\/jjp.88.379_bib110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1081-1206(10)62292-2","article-title":"Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms","volume":"86","author":"Lanier","year":"2001","journal-title":"Ann Allergy Asthma Immun"},{"key":"10.1254\/jjp.88.379_bib111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0420.1999.tb01175.x","article-title":"The added benefit of local patanol therapy when combined with systemic claritin for the inhibition of ocular itching in the conjunctival antigen challenge model","volume":"77","author":"Abelson","year":"1999","journal-title":"Acta Ophthalmol Scand"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819301611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819301611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T19:17:08Z","timestamp":1704568628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819301611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002]]}},"alternative-id":["S0021519819301611"],"URL":"https:\/\/doi.org\/10.1254\/jjp.88.379","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}